Paul You

617 total citations
8 papers, 412 citations indexed

About

Paul You is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul You has authored 8 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul You's work include Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Global Cancer Incidence and Screening (2 papers). Paul You is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Global Cancer Incidence and Screening (2 papers). Paul You collaborates with scholars based in United States, Kazakhstan and China. Paul You's co-authors include Sandra D. Griffith, Melisa Tucker, William B. Capra, Amy P. Abernethy, Michael D. Taylor, Aracelis Z. Torres, Deborah Schrag, Rebecca A. Miksad, Sean Khozin and Brandon Arnieri and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Oncologist.

In The Last Decade

Paul You

8 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul You United States	6	241	191	94	55	44	8	412
Melissa D. Curtis United States	6	258 1.1×	217 1.1×	78 0.8×	68 1.2×	49 1.1×	8	427
Melisa Tucker United States	9	357 1.5×	301 1.6×	123 1.3×	86 1.6×	70 1.6×	13	566
Navdeep Pal United States	11	189 0.8×	127 0.7×	90 1.0×	63 1.1×	55 1.3×	26	689
Nathan C. Nussbaum United States	11	397 1.6×	332 1.7×	154 1.6×	73 1.3×	34 0.8×	22	635
Elisabeth M. Wever Netherlands	9	220 0.9×	400 2.1×	64 0.7×	63 1.1×	40 0.9×	11	536
Brandon Arnieri United States	6	175 0.7×	140 0.7×	93 1.0×	112 2.0×	117 2.7×	10	498
A.L. Vataire France	13	157 0.7×	170 0.9×	158 1.7×	114 2.1×	33 0.8×	34	478
Robin Schaffar Switzerland	10	196 0.8×	126 0.7×	64 0.7×	34 0.6×	14 0.3×	19	338
Talal Hilal United States	15	203 0.8×	136 0.7×	104 1.1×	125 2.3×	41 0.9×	71	700
Gaurav Singal United States	9	127 0.5×	112 0.6×	79 0.8×	26 0.5×	16 0.4×	25	333

Countries citing papers authored by Paul You

Since Specialization

Citations

This map shows the geographic impact of Paul You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul You more than expected).

Fields of papers citing papers by Paul You

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul You. The network helps show where Paul You may publish in the future.

Co-authorship network of co-authors of Paul You

This figure shows the co-authorship network connecting the top 25 collaborators of Paul You. A scholar is included among the top collaborators of Paul You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul You. Paul You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Griffith, Sandra D., Melisa Tucker, Bryan Bowser, et al.. (2019). Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer. Advances in Therapy. 36(8). 2122–2136. 116 indexed citations

Griffith, Sandra D., Rebecca A. Miksad, Paul You, et al.. (2019). Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set. JCO Clinical Cancer Informatics. 3(3). 1–13. 76 indexed citations

O’Connor, Jeremy, Kathi Seidl-Rathkopf, Aracelis Z. Torres, et al.. (2018). Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors. The Oncologist. 23(11). 1388–1390. 17 indexed citations

Curtis, Melissa D., Sandra D. Griffith, Melisa Tucker, et al.. (2018). Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint. Health Services Research. 53(6). 4460–4476. 166 indexed citations

Hermosilla, Sabrina, Paul You, Angela Aifah, et al.. (2017). Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan. PLoS ONE. 12(3). e0172942–e0172942. 20 indexed citations

O’Connor, Jeremy, Kathi Seidl-Rathkopf, Paul You, et al.. (2017). Adoption of immunotherapy into real-world practice: Insights from the use of checkpoint inhibitors.. Journal of Clinical Oncology. 35(15_suppl). e14583–e14583. 2 indexed citations

O’Connor, Jeremy, Kathi Seidl-Rathkopf, Aracelis Z. Torres, et al.. (2017). Racial disparities in the use of programmed death-1 checkpoint inhibitors.. Journal of Clinical Oncology. 35(15_suppl). 3068–3068. 2 indexed citations

Xu, Gaolian, Qimin You, Hongying Wang, et al.. (2010). Application of PCR‐LDR‐nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine. Journal of Medical Virology. 82(7). 1143–1149. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact